Table 3.
Number of individuals (%) per COMT Val158Met and DAT-VNTR genotype group in women living with HIV (n = 64) and without HIV (N = 48).
| COMT Genotype | HIV-positive N= 64 | HIV-negative N= 48 | X2 | p-value |
|---|---|---|---|---|
| AA | 5 (7.8%) | 7 (14.6%) | 0.702 | 0.402 |
| AG | 24 (37.5%) | 15 (31.3%) | 0.237 | 0.626 |
| GG | 35 (54.7%) | 26 (54.2%) | 3.621 × 10−31 | 1 |
| DAT Genotype | ||||
| * /* | 16 (25%) | 9 (18.8%) | 0.310 | 0.577 |
| * /10 | 27 (42.2%) | 23 (47.9%) | 0.169 | 0.681 |
| 10/10 | 21 (32.8%) | 16 (33.3%) | 6.872 × 10−31 | 1 |
This table reports the number of individuals per COMT and DAT genotype according to HIV status. For DAT genotype, * /* refers to genotype absent of a DAT 10-repeat; * /10 refers to genotype heterozygous for a single DAT 10-repeat; 10/10 refers to homozygosity for the 10-repeat allele. P-value indicates the difference in HIV status of participants for each genotype.